UNSPSC 51181546: Glisamuride

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T4C1IE36L0. European Medicines Agency schedules Glisamuride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07929MIG. Glisamuride generally arises in the molecular formula C23H31N5O4S.

UNSPSC 51181546 Glisamuride is a Commodity code for a specific pharmaceutical agent used in diabetes management, but state and local procurement records show no recent solicitation activity under this code. The code nominally covers glisamuride, a sulfonylurea-class antidiabetic drug, which would typically appear in procurement only when a state Medicaid program, county health department, or municipality with a health clinic requires the medication for patient populations. However, the absence of recent opportunities suggests either that glisamuride procurement occurs at higher tiers (such as the Family or Class level) through group purchasing organizations or state formulary contracts, or that demand for this specific agent has diminished in favor of newer antidiabetic classes. Without active solicitation records, no characterization of issuing-body mix, geographic distribution, or representative opportunities is supported.